Similarly, western blot assays showed that endogenous NAT2 protein levels were significantly reduced in hepatoma cells treated with exogenous hsa-miR-15a-3p mimics, compared to the control group (Figures 2C,D). This evidence concerns the gene NAT2 and hepatocellular carcinoma.